Strategies for dissecting genetic-environmental interactions in neurodegenerative disorders

NeuroToxicology

Volumn 27, Issue 5, 2006, Pages 637-657

  Schmechel, Donald E ^a,b   Browndyke, Jeffrey ^a,b   Ghio, Andrew ^a,c  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

Alpha 1 antitrypsin; Alzheimer disease; Anxiety disorders; APOE; Bipolar disorders; Hemochromatosis

Indexed keywords

ALPHA 1 ANTITRYPSIN; APOLIPOPROTEIN E4; HFE PROTEIN; IRON; TRACE ELEMENT;

ADULT; AGE DISTRIBUTION; AGED; AGING; ALCOHOL CONSUMPTION; ANXIETY DISORDER; ARTICLE; BIPOLAR DISORDER; CELL DAMAGE; COGNITIVE DEFECT; COMORBIDITY; CONTROLLED STUDY; DISEASE COURSE; ENVIRONMENTAL EXPOSURE; FATTY LIVER; FEMALE; GENE EXPRESSION; GENE INTERACTION; GENETIC POLYMORPHISM; HUMAN; INFECTION; INFLAMMATION; INNATE IMMUNITY; IRON METABOLISM; LIVER; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; MOOD DISORDER; NERVE CELL DEGENERATION; NUTRITIONAL DEFICIENCY; ONSET AGE; PRIORITY JOURNAL; SLEEP DISORDER; STRESS;

ADULT; AGE FACTORS; AGE OF ONSET; AGED; AGED, 80 AND OVER; AGING; ALPHA 1-ANTITRYPSIN; ANALYSIS OF VARIANCE; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; CHI-SQUARE DISTRIBUTION; CYSTEINE; DNA MUTATIONAL ANALYSIS; ENVIRONMENT; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HEMOCHROMATOSIS; HUMANS; MALE; MIDDLE AGED; MUTATION; NEURODEGENERATIVE DISEASES; PHENOTYPE; RETROSPECTIVE STUDIES; TRYPTOPHAN;

EID: 33747195255     PISSN: 0161813X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuro.2006.05.021     Document Type: Article

References (100)

1. Aldonyte R., Jansson L., Ljungberg O., Larsson S., and Janciauskiene S. Polymerized alpha-antitrypsin is present on lung vascular endothelium. New insights into the biological significance of alpha-antitrypsin polymerisation. Histopathology 45 6 (2004) 587-592
2. Barton J.C., McDonnell S.M., Adams P.C., Brissot P., Powell L.W., Edwards C.Q., et al. Management of hemochromatosis. Hemochromatosis Management Working Group. Ann Int Med 129 11 (1998) 932-939
3. Berlin D., Chong G., Chertkow H., Bergman H., Phillips N.A., and Schipper H.M. Evaluation of HFE (hemochromatosis) mutations as genetic modifiers in sporadic AD and MCI. Neurobiol Aging 25 4 (2004) 465-474
4. Beyer J., Kuchibhatla M., Gersing K., and Krishnan K.R. Medical comorbidity in a bipolar outpatient clinical population. Neuropsychopharmacology 30 2 (2005) 401-404
5. Blanco I., Bustillo E.F., and Rodriguez M.C. Distribution of alpha1-antitrypsin PI S and PI Z frequencies in countries outside Europe: a meta-analysis. Clin Genet 60 6 (2001) 431-441
6. Bosco D., Meda P., Morel P., Matthey-Doret D., Caille D., Toso C., et al. Expression and secretion of alpha1-proteinase inhibitor are regulated by proinflammatory cytokines in human pancreatic islet cells. Diabetologia 48 8 (2005) 1523-1533
7. Brambilla P., Glahn D.C., Balestrieri M., and Soares J.C. Magnetic resonance findings in bipolar disorder. Psychiatr Clin North Am 28 2 (2005) 443-467
8. Breuer W., Greenberg E., and Cabantchik Z.I. Newly delivered transferrin iron and oxidative cell injury. FEBS Lett 403 (1997) 213-219
9. Brieland J.K., Clarke S.J., Karmiol S., Phan S.H., and Fantone J.C. Transferr a potential source of iron for oxygen free radical-mediated endothelial cell injury. Arch Biochem Biophys 294 (1992) 265-270
10. Byth B.C., Billingsley G.D., and Cox D.W. Physical and genetic mapping of the serpin gene cluster at 14q32.1: allelic association and a unique haplotype associated with alpha-1-antitrypsin deficiency. Am J Hum Genet 55 1 (1994) 126-133
11. Cairns N.J., Lee V.M., and Trojanowski J.Q. The cytoskeleton in neurodegenerative diseases. J Pathol 204 4 (2004) 438-449
12. Cardona F., Morcillo S., Gonzalo-Marin M., and Tinahones F.J. The apolipoprotein E genotype predicts postprandial hypertriglyceridemia in patients with the metabolic syndrome. J Clin Endocrinol Metabol 90 5 (2005) 2972-2975
13. Choi J., Malakowsky C.A., Talent J.M., Conrad C.C., and Gracy R.W. Identification of oxidized plasma proteins in Alzheimer's disease. Biochem Biophys Res Commun 293 5 (2002) 1566-1570
14. Colton C.A., Needham L.K., Brown C., Cook D., Rasheed K., Burke J.R., et al. APOE genotype-specific differences in human and mouse macrophage nitric oxide production. J Neuroimmunol 147 1-2 (2004) 62-67
15. Corder E.H., Saunders A.M., Risch N.J., Strittmatter W.J., Schmechel D.E., Gaskell Jr. P.C., et al. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat Genet 7 (1994) 180-184
16. Corder E.H., Saunders A.M., Strittmatter W.J., Schmechel D., Gaskell P., Small G.W., et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer disease in late onset families. Science 261 5123 (1993) 921-923
17. Cotrim H.P., De Freitas L.A., Freitas C., Braga L., Sousa R., Carvalho F., et al. Clinical and histopathological features of NASH in workers exposed to chemicals with or without associated metabolic conditions. Liver Int 24 2 (2004) 131-135
18. Dahl M., Tybjaerg-Hansen A., Sillesen H., Jensen G., Steffensen R., and Nordestgaard B.G. Blood pressure, risk of ischemic cerebrovascular and ischemic heart disease, and longevity in alpha(1)-antitrypsin deficiency: the Copenhagen City Heart Study. Circulation 107 5 (2003) 747-752
19. DeKroon R.M., Mihovilovic M., Goodger Z.V., Robinette J.B., Sullivan P.M., Saunders A.M., et al. ApoE genotype-specific inhibition of apoptosis. J Lipid Res 44 8 (2003) 1566-1573
20. de Serres F.J. Worldwide racial and ethnic distribution of alpha1-antitrypsin deficiency: summary of an analysis of published genetic epidemiologic surveys. Chest 122 5 (2002) 1818-1829
21. de Serres F.J., Blanco I., and Fernandez-Bustillo E. Health implications of alpha1-antitrypsin deficiency in Sub-Sahara African countries and their emigrants in Europe and the New World. Genet Med 7 3 (2005) 175-184
22. Dick F., Semple S., Osborne A., Soutar A., Seaton A., Cherrie J.W., et al. Organic solvent exposure, genes, and risk of neuropsychological impairment. QJM 95 6 (2002) 379-387
23. Facchini F.S., Hua N.W., and Stoohs R.A. Effect of iron depletion in carbohydrate-intolerant patients with clinical evidence of nonalcoholic fatty liver disease. Gastroenterology 122 4 (2002) 931-939
24. Feychting M., Pedersen N.L., Svedberg P., Floderus B., and Gatz M. Dementia and occupational exposure to magnetic fields. Scand J Work Environ Health 24 1 (1998) 46-53
25. Fishel M.A., Watson G.S., Montine T.J., Wang Q., Green P.S., Kulstad J.J., et al. Hyperinsulinemia provokes synchronous increases in central inflammation and beta-amyloid in normal adults. Arch Neurol 62 10 (2005) 1539-1544
26. Gaenzer H., Marschang P., Sturm W., Neumayr G., Vogel W., Patsch J., et al. Association between increased iron stores and impaired endothelial function in patients with hereditary hemochromatosis. J Am College Cardiol 40 12 (2002) 2189-2194
27. Gollin P.A., Kalarai R.N., Eikelenboom P., Rozemuller A., and Perry G. Alpha-1-antitrypsin and alpha-1-antichymotrypsin are in the lesions of Alzheimer's disease. Neuroreport 3 2 (1992) 201-203
28. Goodwin R.D., Jacobi F., and Thefeld W. Mental disorders and asthma in the community. Arch Gen Psychiatr 60 11 (2003) 1125-1130
29. Gottlieb D.J., DeStefano A.L., Foley D.J., Mignot E., Redline S., Givelber R.J., et al. APOE epsilon4 is associated with obstructive sleep apnea/hypopnea: the Sleep Heart Health Study. Neurology 63 4 (2004) 664-668
30. Graziadei I., Gaggl S., Kaserbacher R., Braunsteiner H., and Vogel W. The acute-phase protein alpha 1-antitrypsin inhibits growth and proliferation of human early erythroid progenitor cells (burst-forming units-erythroid) and of human erythroleukemic cells (K562) in vitro by interfering with transferrin iron uptake. Blood 83 1 (1994) 260-268
31. Graziadei I., Kaserbacher R., Braunsteiner H., and Vogel W. The hepatic acute-phase proteins alpha 1-antitrypsin and alpha 2-macroglobulin inhibit binding of transferrin to its receptor. Biochem J 290 Pt 1 (1993) 109-113
32. Graziadei I., Weiss G., Bohm A., Werner-Felmayer G., and Vogel W. Unidirectional upregulation of the synthesis of the major iron proteins, transferrin-receptor and ferritin, in HepG2 cells by the acute-phase protein alpha1-antitrypsin. J Hepatol 27 4 (1997) 716-725
33. Graziadei I., Weiss G., Egger C., Niederwieser D., Patsch J.R., and Vogel W. Modulation of iron metabolism in monocytic THP-1 cells and cultured human monocytes by the acute-phase protein alpha1-antitrypsin. Exp Hematol 26 11 (1998) 1053-1060
34. Hardy J., and Selkoe D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297 5580 (2002) 353-356
35. Hayes V.M. Genetic diversity of the alpha-1-antitrypsin gene in Africans identified using a novel genotyping assay. Hum Mutat 22 1 (2003) 59-66
36. Helmer C., Letenneur L., Rouch I., Richard-Harston S., Barberger-Gateau P., Fabrigoule C., et al. Occupation during life and risk of dementia in French elderly community residents. J Neurol Neurosurg Psychiatr 71 3 (2001) 303-309
37. Hinerfeld D., Traini M.D., Weinberger R.P., Cochran B., Doctrow S.R., Harry J., et al. Endogenous mitochondrial oxidative stress: neurodegeneration, proteomic analysis, specific respiratory chain defects, and efficacious antioxidant therapy in superoxide dismutase 2 null mice. J Neurochem 88 3 (2004) 657-667
38. Hoffmann J., Haendeler J., Aicher A., Rossig L., Vasa M., Zeiher A.M., et al. Aging enhances the sensitivity of endothelial cells toward apoptotic stimuli: important role of nitric oxide. Circ Res 89 8 (2001) 709-715
39. Hubel C.A., Kozlov A.V., Kagan V.E., Evans R.W., Davidge S.T., McLaughlin M.K., et al. Decreased transferrin and increased transferrin saturation in sera of women with preeclampsia: implications for oxidative stress. Am J Obstet Gynecol 175 (1996) 692-700
40. Ikari Y., Mulvihill E., and Schwartz S.M. Alpha 1-proteinase inhibitor, alpha 1-antichymotrypsin, and alpha 2-macroglobulin are the antiapoptotic factors of vascular smooth muscle cells. J Biol Chem 276 15 (2001) 11798-11803
41. Ikebe N., Akaike T., Miyamoto Y., Hayashida K., Yoshitake J., Ogawa M., et al. Protective effect of S-nitrosylated alpha(1)-protease inhibitor on hepatic ischemia-reperfusion injury. J Pharmacol Exp Therap 295 3 (2000) 904-911
42. Janciauskiene S., Moraga F., and Lindgren S. C-terminal fragment of alpha1-antitrypsin activates human monocytes to a pro-inflammatory state through interactions with the CD36 scavenger receptor and LDL receptor. Atherosclerosis 158 1 (2001) 41-51
43. Jayasooriya A.P., Ackland M.L., Mathai M.L., Sinclair A.J., Weisinger H.S., Weisinger R.S., et al. Perinatal omega-3 polyunsaturated fatty acid supply modifies brain zinc homeostasis during adulthood. Proc Natl Acad Sci USA 102 20 (2005) 7133-7138
44. Jehn M., Clark J.M., and Guallar E. Serum ferritin and risk of the metabolic syndrome in US adults. Diab Care 27 10 (2004) 2422-2428
45. Kalivendi S.V., Cunningham S., Kotamraju S., Joseph J., Hillard C.J., and Kalyanaraman B. Alpha-synuclein up-regulation and aggregation during MPP+-induced apoptosis in neuroblastoma cells: intermediacy of transferrin receptor iron and hydrogen peroxide. J Biol Chem 279 15 (2004) 15240-15247
46. Kaup M., Dassler K., Reineke U., Weise C., Tauber R., and Fuchs H. Processing of the human transferrin receptor at distinct positions within the stalk region by neutrophil elastase and cathepsin G. Biol Chem 383 6 (2002) 1011-1020
47. Kessing L.V., and Andersen P.K. Does the risk of developing dementia increase with the number of episodes in patients with depressive disorder and in patients with bipolar disorder?. J Neurol Neurosurg Psychiatr 75 12 (2004) 1662-1666
48. Kilbourne A.M., Cornelius J.R., Han X., Pincus H.A., Shad M., Salloum I., et al. Burden of general medical conditions among individuals with bipolar disorder. Bipolar Disord 6 5 (2004) 368-373
49. Knopman D.S., et al. Practice parameter: diagnosis of dementia (an evidence-based review), Report of the Quality Standards Committee of the American Academy of Neurology. Neurology 56 (2001) 1143-1153
50. Lee V.M., Goedert M., and Trojanowski J.Q. Neurodegenerative tauopathies. Ann Rev Neurosci 24 (2001) 1121-1159
51. Li Y.-J., Oliveira S.A., Xu P., Martin E.R., Stenger J.E., Scherzer C.R., et al. Glutathione S-transferase omega-1 modifies age-at-onset of Alzheimer disease. Hum Mol Genet 24 12 (2003) 3259-3267
52. Liu Y., Choudhury P., Cabral C.M., and Sifers R.N. Oligosaccharide modification in the early secretory pathway directs the selection of a misfolded glycoprotein for degradation by the proteasome. J Biol Chem 274 9 (1999) 5861-5867
53. Lomas D.A., Lourbakos A., Cumming S.A., and Belorgey D. Hypersensitive mousetraps, alpha1-antitrypsin deficiency and dementia. Biochem Soc Trans 30 2 (2002) 89-92
54. Lou J., Triponez F., Oberholzer J., Wang H., Yu D., Buhler L., et al. Expression of alpha-1 proteinase inhibitor in human islet microvascular endothelial cells. Diabetes 48 9 (1999) 1773-1778
55. Mashiba S., Wada Y., Takeya M., Sugiyama A., Hamakubo T., Nakamura A., et al. In vivo complex formation of oxidized alpha(1)-antitrypsin and LDL. Arterioscl Thromb Vasc Biol 21 11 (2001) 1801-1808
56. Matsunaga T., Kotamraju S., Kalivendi S.V., Dhanasekaran A., Joseph J., and Kalyanaraman B. Ceramide-induced intracellular oxidant formation, iron signaling, and apoptosis in endothelial cells: protective role of endogenous nitric oxide. J Biol Chem 279 27 (2004) 28614-28624
57. McCrank E., and Rabheru K. Four cases of progressive supranuclear palsy in patients exposed to organic solvents. Can J Psychiatr Rev Can Psychiatr 34 9 (1989) 934-936
58. McDermott J.H., and Walsh C.H. Hypogonadism in hereditary hemochromatosis. J Clin Endocrinol Metabol 90 4 (2005) 2451-2455
59. Moalem S., Percy M.E., Andrews D.F., Kruck T.P., Wong S., Dalton A.J., et al. Are hereditary hemochromatosis mutations involved in Alzheimer disease?. Am J Med Genet 93 1 (2000) 58-66
60. Moraga F., and Janciauskiene S. Activation of primary human monocytes by the oxidized form of alpha1-antitrypsin. J Biol Chem 275 11 (2000) 7693-7700
61. Moraga F., Lindgren S., and Janciaskiene S. Effects of noninhibitory alpha-1-antitrypsin on primary human monocyte activation in vitro. Arch Biochem Biophys 386 2 (2001) 221-226
62. Mortel K.F., Meyer J.S., Herod B., and Thornby J. Education and occupation as risk factors for dementias of the Alzheimer and ischemic vascular types. Dementia 6 1 (1995) 55-62
63. Mulgrew A.T., Taggart Cc., Lawless M.W., Green C.M., Brantly M.L., O'Neill S.J., et al. Z alpha-1-antitrypsin polymerizes in the lung and serves as a neutrophil chemoattractant. Chest 125 5 (2004) 1607-1609
64. Nilson L.N., Sallsten G., Hagberg S., Backman L., and Barregard L. Influence of solvent exposure and aging on cognitive functioning: an 18 year follow up of formerly exposed floor layers and their controls. Occup Environ Med 59 1 (2002) 49-57
65. Novoradovsky A., Brantly M.L., Waclawiw M.A., Chaudhary P.P., Ihara H., Qi L., et al. Endothelial nitric oxide synthase as a potential susceptibility gene in the pathogenesis of emphysema in alpha-1-antitrypsin deficiency. Am J Respir Cell Mol Biol 20 3 (1999) 441-447
66. Parfrey H., Mahadeva R., and Lomas D.A. Alpha(1)-antitrypsin deficiency, liver disease and emphysema. Int J Biochem Cell Biol 35 7 (2003) 1009-1014
67. Perlmutter D.H. The SEC receptor: a possible link between neonatal hepatitis in alpha 1-antitrypsin deficiency and Alzheimer's disease. Pediatr Res 36 3 (1994) 271-277
68. Petersen R.C., et al. Practice parameter: early detection of mild dementia: mild cognitive impairment (an evidence-based review), Report of the Quality Standards Committee of the American Academy of Neurology. Neurology 56 (2001) 1133-1142
69. Perlmutter D.H. Liver injury in alpha1-antitrypsin deficiency: an aggregated protein induces mitochondrial injury. J Clin Invest 110 11 (2002) 1579-1583
70. Perlmutter D.H. Alpha1-antitrypsin deficiency: liver disease associated with retention of a mutant secretory glycoprotein in the endoplasmic reticulum. Meth Mol Biol 232 (2003) 39-56
71. Pitteloud N., Mootha V.K., Dwyer A.A., Hardin M., Lee H., Eriksson K.F., et al. Relationship between testosterone levels, insulin sensitivity, and mitochondrial function in men. Diab Care 28 7 (2005) 1636-1642
72. Pulliam J.F., Jennings C.D., Kryscio R.J., Davis D.G., Wilson D., Montine T.J., et al. Association of HFE mutations with neurodegeneration and oxidative stress in Alzheimer's disease and correlation with APOE. Am J Med Genet Part B Neuropsychiatr Genet Off Publ Int Soc Psychiatr Genet 119 1 (2003) 48-53
73. Qiu C., Fratiglioni L., Karp A., Winblad B., and Bellander T. Occupational exposure to electromagnetic fields and risk of Alzheimer's disease. Epidemiology 15 6 (2004) 687-694
74. Qiu C., Karp A., von Strauss E., Winblad B., Fratiglioni L., and Bellander T. Lifetime principal occupation and risk of Alzheimer's disease in the Kungsholmen project. Am J Indust Med 43 2 (2003) 204-211
75. Salvi R.M., Lara D.R., Ghisolfi E.S., Portela L.V., Dias R.D., and Souza D.O. Neuropsychiatric evaluation in subjects chronically exposed to organophosphate pesticides. Toxicol Sci 72 2 (2003) 267-271
76. Sambamurti K., Granholm A.C., Kindy M.S., Bhat N.R., Greig N.H., Lahiri D.K., et al. Cholesterol and Alzheimer's disease: clinical and experimental models suggest interactions of different genetic, dietary and environmental risk factors. Curr Drug Targets 5 6 (2004) 517-528
77. Schmechel D.E. Relationship between apolipoprotein E and susceptibility of neuro-degenerative disease. In: Briley M., and Sulser F. (Eds). Molecular genetics of mental disorders (2001), Martin Dunitz, London
78. Schmechel D.E., Burkhart D.S., Ange R., and Izard M.K. Cholinergic axonal dystrophy and mitochondrial pathology in prosimian primates. Exp Neurol 142 1 (1996) 11-127
79. Schmechel D.E., Saunders A.M., Strittmatter W.J., Crain B.J., Hulette C.M., Joo S.H., et al. Increased amyloid ß-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer's disease. PNAS (USA) 90 20 (1993) 9649-9653
80. Schmechel D.E., Tiller M.O., Han S.-H., Fail P., Ange R., Burkhart D.S., et al. Pattern of apolipoprotein-E immunoreactivity during brain aging. In: Roses A.D., Weisgraber K., and Christen Y. (Eds). Apolipo-protein E and Alzheimer's disease (1996), Y. Springer-Verlag, Berlinn, Heidelberg 27-48
81. Schulte P.A., Burnett C.A., Boeniger M.F., and Johnson J. Neurodegenerative diseases: occupational occurrence and potential risk factors, 1982 through 1991. Am J Public Health 86 9 (1996) 1281-1288
82. Seixas S., Garcia O., Trovoada M.J., Santos M.T., Amorim A., and Rocha J. Patterns of haplotype diversity within the serpin gene cluster at 14q32.1: insights into the natural history of the alpha1-antitrypsin polymorphism. Hum Genet 108 1 (2001) 20-30
83. Shang T., Kotamraju S., Kalivendi S.V., Hillard C.J., and Kalyanaraman B. 1-Methyl-4-phenylpyridinium-induced apoptosis in cerebellar granule neurons is mediated by transferrin receptor iron-dependent depletion of tetrahydrobiopterin and neuronal nitric-oxide synthase-derived superoxide. J Biol Chem 279 18 (2004) 19099-19112
84. Stern Y., Gurland B., Tatemichi T.K., Tang M.X., Wilder D., and Mayeux R. Influence of education and occupation on the incidence of Alzheimer's disease. JAMA 271 13 (1994) 1004-1010
85. Stewart W.F., Schwartz B.S., Simon D., Kelsey K., and Todd A.C. ApoE genotype, past adult lead exposure, and neurobehavioral function. Environ Health Perspect 110 5 (2002) 501-505
86. Strittmatter W.J., Weisgraber K.H., Huang D.Y., Dong L.M., Salvesen G.S., Pericak-Vance M., et al. Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease. Proc Natl Acad Sci USA 90 17 (1993) 8098-8102
87. Sun Y.X., Minthon L., Wallmark A., Warkentin S., Blennow K., and Janciauskiene S. Inflammatory markers in matched plasma and cerebrospinal fluid from patients with Alzheimer's disease. Dement Geriatr Cogn Disord 16 3 (2003) 136-144
88. Talmud P.J., et al. Progression of atherosclerosis is associated with variation in the alpha1-antitrypsin gene. Arterioscler Thromb Vasc Biol 23 4 (2003) 644-649
89. Teckman J.H., An J.K., Blomenkamp K., Schmidt B., and Perlmutter D. Mitochondrial autophagy and injury in the liver in alpha 1-antitrypsin deficiency. Am J Physiol Gastrointest Liver Physiol 286 5 (2004) G851-G862
90. Teckman J.H., An J.K., Loethen S., and Perlmutter D.H. Fasting in alpha1-antitrypsin deficient liver: constitutive activation of autophagy. Am J Physiol Gastrointest Liver Physiol 283 5 (2002) G1156-G1165
91. Teckman J.H., and Perlmutter D.H. Retention of mutant alpha(1)-antitrypsin Z in endoplasmic reticulum is associated with an autophagic response. Am J Physiol Gastrointest Liver Physiol 279 5 (2000) G961-G974
92. Valenti L., Dongiovanni P., Fracanzani A.L., Santorelli G., Fatta E., Bertelli C., et al. Increased susceptibility to nonalcoholic fatty liver disease in heterozygotes for the mutation responsible for hereditary hemochromatosis. Digest Liver Dis 35 3 (2003) 172-178
93. van Gelder W., Huijskes-Heins M.I., Cleton-Soeteman M.I., van Dijk J.P., and van Eijk H.G. Iron uptake in blood-brain barrier endothelial cells cultured in iron-depleted and iron-enriched media. J Neurochem 71 3 (1998) 1134-1140
94. Wang C., Wilson W.A., Moore S.D., Mace B.E., Maeda N., Schmechel D.E., and Sullivan P.M. Human apoE4-targeted replacement mice display synaptic deficits in the absence of neuropathology. Neurobiology of Disease 18 2 (2005) 390-398
95. Weiss G., Graziadel I., Urbanek M., Grunewald K., and Vogel W. Divergent effects of alpha 1-antitrypsin on the regulation of iron metabolism in human erythroleukaemic (K562) and myelomonocytic (THP-1) cells. Biochem J 319 Pt 3 (1996) 897-902
96. Wetterling T., and Tegtmeyer K.F. Serum alpha-1-antitrypsin and alpha-2-macroglobulin in Alzheimer's and Binswanger's disease. Clin Invest 72 3 (1994) 196-199
97. White L., Katzman R., Losonczy K., Salive M., Wallace R., Berkman L., et al. Association of education with incidence of cognitive impairment in three established populations for epidemiologic studies of the elderly. J Clin Epidemiol 47 4 (1994) 363-374
98. Wilson R.S., Schneider J.A., Barnes L.L., Beckett L.A., Aggarwal N.T., Cochran E.J., et al. The apolipoprotein E epsilon 4 allele and decline in different cognitive systems during a 6-year period. Arch Neurol 59 7 (2002) 1154-1160
99. Yang H., Zhang W.J., Wu L.Q., Gu F., Ye L.Y., Li J., et al. Protection of liver sinusoidal endothelial cells from hypoxia-reoxygenation induced apoptosis by alpha-1 antitrypsin in vitro. Chung-Hua i Hsueh Tsa Chih [Chin Med J] 85 2 (2005) 106-110 [in Chinese]
100. Zandi P.P., Willour V.L., Huo Y., Chellis J., Potash J.B., MacKinnon D.F., et al. Genome screen of a second wave of NIMH genetics initiative bipolar pedigrees: chromosomes 2, 11, 13, 14, and X. Am J Hum Genet 119B 1 (2003) 69